These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24060719)

  • 21. AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II.
    Ko AR; Jin DK; Cho SY; Park SW; Przybylska M; Yew NS; Cheng SH; Kim JS; Kwak MJ; Kim SJ; Sohn YB
    Mol Genet Metab; 2016 Apr; 117(4):447-55. PubMed ID: 26857995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of I-cell disease (mucolipidosis II) presenting with craniosynostosis.
    Aynaci FM; Cakir E; Aynaci O
    Childs Nerv Syst; 2002 Dec; 18(12):707-11. PubMed ID: 12483356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosis.
    Yang M; Cho SY; Park HD; Choi R; Kim YE; Kim J; Lee SY; Ki CS; Kim JW; Sohn YB; Song J; Jin DK
    Orphanet J Rare Dis; 2017 Jan; 12(1):11. PubMed ID: 28095893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel intermediate mucolipidosis II/IIIαβ caused by GNPTAB mutation in the cytosolic N-terminal domain.
    Leroy JG; Sillence D; Wood T; Barnes J; Lebel RR; Friez MJ; Stevenson RE; Steet R; Cathey SS
    Eur J Hum Genet; 2014 May; 22(5):594-601. PubMed ID: 24045841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations.
    Encarnação M; Lacerda L; Costa R; Prata MJ; Coutinho MF; Ribeiro H; Lopes L; Pineda M; Ignatius J; Galvez H; Mustonen A; Vieira P; Lima MR; Alves S
    Clin Genet; 2009 Jul; 76(1):76-84. PubMed ID: 19659762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare Association of Mucolipidosis III alpha/beta with Dilated Cardiomyopathy.
    Kwak MJ; Lee HW; Kim YM; Cho SY; Park HD; Jin DK
    Ann Clin Lab Sci; 2018 Nov; 48(6):785-789. PubMed ID: 30610051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two homozygous nonsense mutations of GNPTAB gene in two Chinese families with mucolipidosis II alpha/beta using targeted next-generation sequencing.
    Yang Y; Wu J; Liu H; Chen X; Wang Y; Zhao M; He X
    Genomics; 2013 Sep; 102(3):169-73. PubMed ID: 23773965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pathology of murine mucolipidosis types II and IIIC.
    Vogel P; Payne BJ; Read R; Lee WS; Gelfman CM; Kornfeld S
    Vet Pathol; 2009 Mar; 46(2):313-24. PubMed ID: 19261645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neonate with mucolipidosis II and transient secondary hyperparathyroidism.
    Leyva C; Buch M; J Wierenga K; Berkovitz G; Seeherunvong T
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1399-1402. PubMed ID: 31758855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucolipidosis type II α/β with a homozygous missense mutation in the GNPTAB gene.
    Coutinho MF; Santos Lda S; Girisha KM; Satyamoorthy K; Lacerda L; Prata MJ; Alves S
    Am J Med Genet A; 2012 May; 158A(5):1225-8. PubMed ID: 22495880
    [No Abstract]   [Full Text] [Related]  

  • 31. Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III.
    Raas-Rothschild A; Bargal R; Goldman O; Ben-Asher E; Groener JE; Toutain A; Stemmer E; Ben-Neriah Z; Flusser H; Beemer FA; Penttinen M; Olender T; Rein AJ; Bach G; Zeigler M
    J Med Genet; 2004 Apr; 41(4):e52. PubMed ID: 15060128
    [No Abstract]   [Full Text] [Related]  

  • 32. Mannose 6-phosphate-dependent targeting of lysosomal enzymes is required for normal craniofacial and dental development.
    Koehne T; Markmann S; Schweizer M; Muschol N; Friedrich RE; Hagel C; Glatzel M; Kahl-Nieke B; Amling M; Schinke T; Braulke T
    Biochim Biophys Acta; 2016 Sep; 1862(9):1570-80. PubMed ID: 27239697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease).
    Wang P; Mazrier H; Caverly Rae J; Raj K; Giger U
    BMC Vet Res; 2018 Dec; 14(1):416. PubMed ID: 30591066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations.
    Ben-Yoseph Y; Mitchell DA; Yager RM; Wei JT; Chen TH; Shih LY
    Am J Hum Genet; 1992 Jan; 50(1):137-44. PubMed ID: 1309624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients.
    Bargal R; Zeigler M; Abu-Libdeh B; Zuri V; Mandel H; Ben Neriah Z; Stewart F; Elcioglu N; Hindi T; Le Merrer M; Bach G; Raas-Rothschild A
    Mol Genet Metab; 2006 Aug; 88(4):359-63. PubMed ID: 16630736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB).
    De Pace R; Coutinho MF; Koch-Nolte F; Haag F; Prata MJ; Alves S; Braulke T; Pohl S
    Hum Mutat; 2014 Mar; 35(3):368-76. PubMed ID: 24375680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inappropriate cathepsin K secretion promotes its enzymatic activation driving heart and valve malformation.
    Lu PN; Moreland T; Christian CJ; Lund TC; Steet RA; Flanagan-Steet H
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined in vitro and in silico analyses of missense mutations in GNPTAB provide new insights into the molecular bases of mucolipidosis II and III alpha/beta.
    Danyukova T; Ludwig NF; Velho RV; Harms FL; Güneş N; Tidow H; Schwartz IV; Tüysüz B; Pohl S
    Hum Mutat; 2020 Jan; 41(1):133-139. PubMed ID: 31579991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA.
    Paik KH; Song SM; Ki CS; Yu HW; Kim JS; Min KH; Chang SH; Yoo EJ; Lee IJ; Kwan EK; Han SJ; Jin DK
    Hum Mutat; 2005 Oct; 26(4):308-14. PubMed ID: 16116615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.
    Qian Y; van Meel E; Flanagan-Steet H; Yox A; Steet R; Kornfeld S
    J Biol Chem; 2015 Jan; 290(5):3045-56. PubMed ID: 25505245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.